Riskpilot← Back to searchSign inGet full accessNORSK BIO AS
ASActiveOrg 913445368Hesbyveien 18A, 3171 SemOther specialised construction activities n.e.c. · NACE 4399Est. 20140 employees
Revenue 2023
NOK 12,7M
+91% vs 2022
EBITDA margin
24.0%
+213% vs 2022
Equity ratio
40.1%
Financial strength
Net profit 2023
NOK 3,6M
+444% vs 2022
| Revenue | NOK 12,7M | +91% |
| EBITDA | NOK 3,1M | +213% |
| Net profit | NOK 3,6M | +444% |
| Total assets | NOK 26,2M | +79% |
| Equity | NOK 10,5M | +1092% |
| Employees | 0 | — |
Legal name
NORSK BIO AS
Org number
913445368
Legal form
Aksjeselskap
NACE code
4399 · Other specialised construction activities n.e.c.
Founded
31. mars 2014
Share capital
NOK 964 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Kjøp og salg av biobrensel.
Address
Hesbyveien 18A, 3171 Sem
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 5 343 | 3 196 | 4 523 | 6 663 | 12 739 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −1 210 | −349 | 776 | 974 | 3 053 |
| Depreciation & amort. | −1 548 | −1 548 | −1 545 | −1 531 | −1 493 |
| EBIT | −2 757 | −1 896 | −768 | −557 | 1 559 |
| Net financials | −663 | −492 | −467 | −476 | −532 |
| Profit before tax | −3 420 | −2 388 | −1 235 | −1 033 | 1 028 |
| Tax | −0 | −0 | −0 | −0 | −2 530 |
| Net profit | −3 420 | −2 388 | −1 235 | −1 033 | 3 558 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 19 090 | 17 565 | 17 265 | 14 695 | 26 241 |
| Equity | 3 567 | 1 179 | −28 | −1 062 | 10 529 |
| Long-term debt | 11 708 | 11 128 | 10 750 | 14 122 | 9 256 |
| Short-term debt | 3 815 | 5 259 | 6 543 | 1 635 | 6 456 |
| Total debt | 15 523 | 16 387 | 17 293 | 15 757 | 15 711 |
EBITDA margin
24.0%
This company
15.8%
Market median
+52% vs market
20192023
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20192023
Return on equity
33.8%
This company
18.4%
Market median
+84% vs market
20192023
Net profit margin
27.9%
This company
8.1%
Market median
+244% vs market
20192023
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20192023
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HK Chief Executive Officer | Chief Executive Officer | 2014 |
| Former (1) | ||
RI Observer | Observer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (4) | ||
| Chairman | 2019 – 2022 | |
| Board of Directors | 2023 – 2023 | |
| Chairman | 2023 – 2023 | |
| Board of Directors | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 16.34% | 16.34% | 2022 | |
| Company | 16.34% | 16.34% | 2022 | |
| Company | 16.34% | 16.34% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fanebust Holding As
NORSK BIO AS Board members of NORSK BIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Kjæreng | Chief Executive Officer | 0 companies |
| Rune Isachsen | Observer | 0 companies |
| Leif-Martin Drange | Board of Directors | 0 companies |
| Morten Dahl | Chairman | 0 companies |
| Tommy Fanebust | Board of Directors | 0 companies |
| Lauri Tapio Matikainen | Board of Directors | 0 companies |
| Knut Grothaug | Chairman | 0 companies |
| Kari Matti Aulasmaa | Chairman | 0 companies |
| Jo Are Haug | Board of Directors | 0 companies |